411
Views
26
CrossRef citations to date
0
Altmetric
Research Paper

Secreted klotho protein attenuates osteogenic differentiation of human bone marrow mesenchymal stem cells in vitro via inactivation of the FGFR1/ERK signaling pathway

, , , , , , & show all
Pages 356-365 | Received 20 Sep 2015, Accepted 12 Oct 2015, Published online: 25 Nov 2015

References

  • Bianco P, Riminucci M, Gronthos S, Robey PG. 2001. Bone marrow stromal stem cells: Nature, biology, and potential applications. Stem Cells 19:180–192
  • Camilli TC, Xu M, O’Connell MP, Chien B, Frank BP, Subaran S, Indig FE, et al. 2011. Loss of klotho during melanoma progression leads to increased filamin cleavage, increased wnt5a expression, and enhanced melanoma cell motility. Pigm Cell Melanoma R 24:175–186
  • Chan JJ, Cupples LA, Kiel DP, O’Donnell CJ, Hoffmann U, Samelson EJ. 2015. Qct volumetric bone mineral density and vascular and valvular calcification: The framingham study. J Bone Miner Res 30:1767–1774
  • Chen CD, Li H, Liang J, Hixson K, Zeldich E, Abraham CR. 2014. The anti-aging and tumor suppressor protein klotho enhances differentiation of a human oligodendrocytic hybrid cell line. J Mol Neurosci 55:76–90
  • Du X, Xie Y, Xian CJ, Chen L. 2012. Role of fgfs/fgfrs in skeletal development and bone regeneration. J Cell Physiol 227:3731–3743
  • El-Hoss J, Cheng T, Carpenter EC, Sullivan K, Deo N, Mikulec K, Little DG, et al. 2014. A combination of rhbmp-2 (recombinant human bone morphogenetic protein-2) and mek (map kinase/erk kinase) inhibitor pd0325901 increases bone formation in a murine model of neurofibromatosis type i pseudarthrosis. J Bone Joint Surg Am 96:e117
  • Eswarakumar VP, Lax I, Schlessinger J. 2005. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 16:139–149
  • Franceschi RT, Xiao G. 2003. Regulation of the osteoblast-specific transcription factor, runx2: Responsiveness to multiple signal transduction pathways. J Cell Biochem 88:446–454
  • Guan SM, Wang ZM, Xin F, Xin HP. 2014. Wnt5a is associated with the differentiation of bone marrow mesenchymal stem cells in vascular calcification by connecting with different receptors. Mol Med Rep 10:1985–1991
  • Guan X, Nie L, He T, Yang K, Xiao T, Wang S, Huang Y, et al. 2014. Klotho suppresses renal tubulo-interstitial fibrosis by controlling basic fibroblast growth factor-2 signalling. J Pathol 234:560–572
  • Han X, Xiao Z, Quarles LD. 2015. Membrane and integrative nuclear fibroblastic growth factor receptor (fgfr) regulation of fgf-23. J Biol Chem 290:10447–10459
  • Hanada K, Dennis JE, Caplan AI. 1997. Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. J Bone Miner Res 12:1606–1614
  • Hiyama A, Arai F, Sakai D, Yokoyama K, Mochida J. 2012. The effects of oxygen tension and antiaging factor klotho on wnt signaling in nucleus pulposus cells. Arthritis Res Ther 14:R105
  • Hu MC, Kuro-o M, Moe OW. 2010. Klotho and kidney disease. J Nephrol 23:S136–S144
  • Hu MC, Shi M, Zhang J, Quinones H, Griffith C, Kuro-o M, Moe OW. 2011. Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol 22:124–136
  • Jacob AL, Smith C, Partanen J, Ornitz DM. 2006. Fibroblast growth factor receptor 1 signaling in the osteo-chondrogenic cell lineage regulates sequential steps of osteoblast maturation. Dev Biol 296:315–328
  • Kalbasi Anaraki P, Patecki M, Larmann J, Tkachuk S, Jurk K, Haller H, Theilmeier G, et al. 2014. Urokinase receptor mediates osteogenic differentiation of mesenchymal stem cells and vascular calcification via the complement c5a receptor. Stem Cells Dev 23:352–362
  • Kawano K, Ogata N, Chiano M, Molloy H, Kleyn P, Spector TD, Uchida M, et al. 2002. Klotho gene polymorphisms associated with bone density of aged postmenopausal women. J Bone Miner Res 17:1744–1751
  • Koizumi M, Komaba H, Fukagawa M. 2013. Parathyroid function in chronic kidney disease: Role of fgf23-klotho axis. Contrib Nephrol 180:110–123
  • Komaba H, Goto S, Fujii H, Hamada Y, Kobayashi A, Shibuya K, Tominaga Y, et al. 2009. Depressed expression of klotho and fgf receptor 1 in hyperplastic parathyroid glands from uremic patients. Kidney Int 77:232–238
  • Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, et al. 1997. Targeted disruption of cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755–764
  • Kramann R, Couson SK, Neuss S, Kunter U, Bovi M, Bornemann J, Knuchel R, et al. 2011. Exposure to uremic serum induces a procalcific phenotype in human mesenchymal stem cells. Arterioscler Thromb Vasc Biol 31:e45–e54
  • Kuro-o M. 2006. Klotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolism. Curr. Opin. Nephrol. Hypertens. 15:437–441
  • Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, et al. 1997. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390:45–51
  • Kurosu H, Yamamoto M, Clark JD, Pastor JV, Nandi A, Gurnani P, McGuinness OP, et al. 2005. Suppression of aging in mice by the hormone klotho. Science 309:1829–1833
  • Lampropoulos CE, Papaioannou I, D’Cruz DP. 2012. Osteoporosis-a risk factor for cardiovascular disease? Nat Rev Rheumatol 8:587–598
  • Li Y, He X, Olauson H, Larsson TE, Lindgren U. 2013. Fgf23 affects the lineage fate determination of mesenchymal stem cells. Calcif Tissue Int 93:556–564
  • Maekawa Y, Ishikawa K, Yasuda O, Oguro R, Hanasaki H, Kida I, Takemura Y, et al. 2009. Klotho suppresses tnf-alpha-induced expression of adhesion molecules in the endothelium and attenuates nf-kappab activation. Endocrine 35:341–346
  • Marie PJ. 2012. Fibroblast growth factor signaling controlling bone formation: An update. Gene 498:1–4
  • Matsumura Y, Aizawa H, Shiraki-Iida T, Nagai R, Kuro-o M, Nabeshima Y. 1998. Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein. Biochem Biophys Res Commun 242:626–630
  • Mencke R, Harms G, Mirkovic K, Struik J, Van Ark J, Van Loon E, Verkaik M, et al. 2015. Membrane-bound klotho is not expressed endogenously in healthy or uraemic human vascular tissue. Cardiovasc Res pii: cvv187. [Epub ahead of print]
  • Muenke M, Schell U, Hehr A, Robin NH, Losken HW, Schinzel A, Pulleyn LJ, et al. 1994. A common mutation in the fibroblast growth factor receptor 1 gene in pfeiffer syndrome. Nat Genet 8:269–274
  • Mullin BH, Wilson SG, Islam FM, Calautti M, Dick IM, Devine A, Prince RL. 2005. Klotho gene polymorphisms are associated with osteocalcin levels but not bone density of aged postmenopausal women. Calcif Tissue Int 77:145–151
  • Ogata N, Matsumura Y, Shiraki M, Kawano K, Koshizuka Y, Hosoi T, Nakamura K, et al. 2002. Association of klotho gene polymorphism with bone density and spondylosis of the lumbar spine in postmenopausal women. Bone 31:37–42
  • Peterson JR, Eboda ON, Brownley RC, Cilwa KE, Pratt LE, De La Rosa S, Agarwal S, et al. 2015. Effects of aging on osteogenic response and heterotopic ossification following burn injury in mice. Stem Cells Dev 24:205–213
  • Potter BK, Forsberg JA, Davis TA, Evans KN, Hawksworth JS, Tadaki D, Brown TS, et al. 2010. Heterotopic ossification following combat-related trauma. J Bone Joint Surg Am 92:74–89
  • Ranganathan K, Loder S, Agarwal S, Wong VC, Forsberg J, Davis TA, Wang S, et al. 2015. Heterotopic ossification: Basic-science principles and clinical correlates. J Bone Joint Surg Am 97:1101–1111
  • Riancho JA, Valero C, Hernandez JL, Ortiz F, Zarrabeitia A, Alonso MA, Pena N, et al. 2007. Association of the f352v variant of the klotho gene with bone mineral density. Biogerontology 8:121–127
  • Saucedo L, Buffa GN, Rosso M, Guillardoy T, Gongora A, Munuce MJ, Vazquez-Levin MH, et al. 2015. Fibroblast growth factor receptors (FGFRs) in human sperm: Expression, functionality and involvement in motility regulation. PLoS One 10:e0127297
  • Schell U, Hehr A, Feldman GJ, Robin NH, Zackai EH, de Die-Smulders C, Viskochil DH, et al. 1995. Mutations in fgfr1 and fgfr2 cause familial and sporadic pfeiffer syndrome. Hum Mol Genet 4:323–328
  • Shalhoub V, Ward SC, Sun B, Stevens J, Renshaw L, Hawkins N, Richards WG. 2011. Fibroblast growth factor 23 (fgf23) and alpha-klotho stimulate osteoblastic mc3t3.E1 cell proliferation and inhibit mineralization. Calcif Tissue Int 89:140–150
  • Shimoyama Y, Nishio K, Hamajima N, Niwa T. 2009. Klotho gene polymorphisms g-395a and c1818t are associated with lipid and glucose metabolism, bone mineral density and systolic blood pressure in Japanese healthy subjects. Clin Chim Acta 406:134–138
  • Suda RK, Billings PC, Egan KP, Kim JH, McCarrick-Walmsley R, Glaser DL, Porter DL, et al. 2009. Circulating osteogenic precursor cells in heterotopic bone formation. Stem Cells 27:2209–2219
  • Urakawa I, Yamazaki Y, Shimada T, Iijima K, Hasegawa H, Okawa K, Fujita T, et al. 2006. Klotho converts canonical FGF receptor into a specific receptor for fgf23. Nature 444:770–774
  • Wang HL, Xu Q, Wang Z, Zhang YH, Si LY, Li XJ, Yang QH, et al. 2010. A potential regulatory single nucleotide polymorphism in the promoter of the klotho gene may be associated with essential hypertension in the Chinese Han population. Clin Chim Acta 411:386–390
  • Wang Y, Sun Z. 2009. Current understanding of klotho. Ageing Res Rev 8:43–51
  • Wang YH, Liu Y, Maye P, Rowe DW. 2006. Examination of mineralized nodule formation in living osteoblastic cultures using fluorescent dyes. Biotechnol Prog 22:1697–1701
  • White KE, Cabral JM, Davis SI, Fishburn T, Evans WE, Ichikawa S, Fields J, et al. 2005. Mutations that cause osteoglophonic dysplasia define novel roles for fgfr1 in bone elongation. Am J Hum Genet 76:361–367
  • Xiao G, Jiang D, Thomas P, Benson MD, Guan K, Karsenty G, Franceschi RT. 2000. Mapk pathways activate and phosphorylate the osteoblast-specific transcription factor, cbfa1. J Biol Chem 275:4453–4459
  • Xu Y, Sun, Z. 2015. Molecular basis of klotho: From gene to function in aging. Endocr Rev 36:174–193
  • Zhou X, Tao Y, Wang J, Liang C, Wang J, Li H, Chen Q. 2015. Roles of fgf-2 and tgf-beta/fgf-2 on differentiation of human mesenchymal stem cells towards nucleus pulposus-like phenotype. Growth Factors 33:23–30
  • Zhou YX, Xu X, Chen L, Li C, Brodie SG, Deng CX. 2000. A pro250arg substitution in mouse fgfr1 causes increased expression of cbfa1 and premature fusion of calvarial sutures. Hum Mol Genet 9:2001–2008

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.